Opaleye Management reports $29,593 Grace Therapeutics common share purchase

Opaleye Management, a 10% owner of Grace Therapeutics, reported open-market purchases of 14,632 common shares. Purchases were priced at USD 2.0175, USD 2.0446, USD 2.02 per share. Indirect beneficial ownership rose to 2,873,289 shares held through Opaleye, L.P. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grace Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-046899), on October 13, 2026, and is solely responsible for the information contained therein. (C)